Valeo Financial Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-45
| Closed | -$6K | – | 501 |
|
|
2021
Q1 | $6K | Sell |
45
-2
| -4% | -$267 | ﹤0.01% | 1402 |
|
|
2020
Q4 | $6K | Hold |
47
| – | – | ﹤0.01% | 1283 |
|
|
2020
Q3 | $7K | Sell |
47
-66
| -58% | -$9.83K | ﹤0.01% | 1115 |
|
|
2020
Q2 | $17K | Hold |
113
| – | – | ﹤0.01% | 1045 |
|
|
2020
Q1 | $13K | Buy |
113
+64
| +131% | +$7.36K | ﹤0.01% | 953 |
|
|
2019
Q4 | $6K | Hold |
49
| – | – | ﹤0.01% | 1202 |
|
|
2019
Q3 | $4K | Hold |
49
| – | – | ﹤0.01% | 1209 |
|
|
2019
Q2 | $4K | Sell |
49
-7
| -13% | -$571 | ﹤0.01% | 1233 |
|
|
2019
Q1 | $5K | Hold |
56
| – | – | ﹤0.01% | 1129 |
|
|
2018
Q4 | $4K | Hold |
56
| – | – | ﹤0.01% | 1108 |
|
|
2018
Q3 | $4K | Buy |
56
+5
| +10% | +$357 | ﹤0.01% | 1237 |
|
|
2018
Q2 | $5K | Hold |
51
| – | – | ﹤0.01% | 1107 |
|
|
2018
Q1 | $6K | Hold |
51
| – | – | ﹤0.01% | 1058 |
|
|
2017
Q4 | $6K | Hold |
51
| – | – | ﹤0.01% | 945 |
|
|
2017
Q3 | $6K | Buy |
+51
| New | +$6K | ﹤0.01% | 807 |
|